Zealand Pharma A/S

The conference will begin shortly. To raise your hand during Q&A, you can dial star 1 1. The conference will begin shortly. To raise your hand during Q&A, you can dial star 1 1.

Good day and thank you for standing by. Welcome to Zealand Pharma results for third quarter 2022 conference call. At this time all participants are in listen-only mode. After the speaker presentation there will be the question and answer session. To ask a question during the session you need to press star 1 1 on your telephone keypad. You will then hear an automatic message advising your hand is raised. Please be advised that today's conference has been recorded. I would now like to hand the conference over to a speaker today, Anna Krasowska. Please go ahead.

Thank you, operator. Welcome, and thank you for joining us today to discuss Zealand's third quarter results for 2022. I'm Anna Krasowska, Vice President of Investor Relations and Corporate Communications at Zealand. With me today to review the items on slide two are the following members of Zealand's management team. Adam Stainsberg, President and Chief Executive Officer, Henrietta Venica, Chief Financial Officer, and David Kendall, Chief Medical Officer. You can also find the related company announcement and supporting information on our website at zeelandpharma.com. I would like to point out, as described on slide three, that we will be making forward-looking statements that are subject to risks and uncertainties. With that, I will turn the call over to Adam Stainsberg, President and CEO. Adam?